Patients’ Attitudes and Physicians’ Perceptions Toward Maintenance Therapy for Advanced Non–Small‐cell Lung Cancer: A Multicenter Italian Survey

[1]  J. Rosińćzuk,et al.  Quality of life of patients with lung cancer , 2016, OncoTargets and therapy.

[2]  C. Gridelli,et al.  Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. , 2014, Clinical lung cancer.

[3]  E. Russo,et al.  Adherence to therapy and adverse drug reactions: is there a link? , 2014, Expert opinion on drug safety.

[4]  C. Gridelli,et al.  PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Giese-Davis,et al.  Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age , 2012, BMC Cancer.

[6]  D. Gerber,et al.  Patient comprehension and attitudes toward maintenance chemotherapy for lung cancer. , 2012, Patient education and counseling.

[7]  C. Dooms,et al.  Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  D. Howell,et al.  Distress-the 6th vital sign. , 2011, Current oncology.

[9]  P. Davidson,et al.  Decisions for lung cancer chemotherapy: the influence of physician and patient factors , 2011, Supportive Care in Cancer.

[10]  A. Argiris,et al.  Maintenance Therapy for Advanced-Non Small Cell Lung Cancer , 2010 .

[11]  Joseph D Tariman,et al.  Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  S. O’Connor,et al.  Screening for psychological distress in patients with lung cancer: results of a clinical audit evaluating the use of the patient Distress Thermometer , 2010, Supportive Care in Cancer.

[13]  Jayne Tierney,et al.  Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Burdett,et al.  Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group , 2008 .

[15]  R. Radinsky,et al.  Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models , 2008 .

[16]  D. Chu,et al.  Patient attitudes towards chemotherapy as assessed by patient versus physician: a prospective observational study in advanced non-small cell lung cancer. , 2007, Lung cancer.

[17]  C. Dooms,et al.  The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer , 2006, Expert review of anticancer therapy.

[18]  R. Barbour.  Making sense of focus groups , 2005, Medical education.

[19]  M. Adachi,et al.  Patients preferences in chemotherapy for advanced non-small-cell lung cancer. , 2005, Internal medicine.

[20]  S. Holm,et al.  Patient–physician communication concerning participation in cancer chemotherapy trials , 2004, British Journal of Cancer.

[21]  E. Bruera,et al.  Patient preferences versus physician perceptions of treatment decisions in cancer care. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[23]  J P Kassirer,et al.  Incorporating patients' preferences into medical decisions. , 1994, The New England journal of medicine.

[24]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[25]  D. Morgan.  Focus groups for qualitative research. , 1988, Hospital guest relations report.

[26]  Joseph D Tariman,et al.  Physician, patient, and contextual factors affecting treatment decisions in older adults with cancer and models of decision making: a literature review. , 2012, Oncology nursing forum.

[27]  P. Butow,et al.  Psychological responses of patients receiving a diagnosis of cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Alfred A. Bartolucci,et al.  Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1996 .